Suppr超能文献

长期抗凝对全膝关节置换术后早期手术结果的影响:一项TriNetX数据库研究

The Effect of Chronic Anticoagulation on Early Postoperative Outcomes Following Total Knee Arthroplasty: A TriNetX Database Study.

作者信息

Johnson Andrea H, Brennan Jane C, Simpson Shawn S, Turcotte Justin J, King Paul J

机构信息

Department of Orthopedics, Luminis Health Anne Arundel Medical Center, Annapolis, MD, USA.

出版信息

Arthroplast Today. 2025 Apr 26;33:101690. doi: 10.1016/j.artd.2025.101690. eCollection 2025 Jun.

Abstract

BACKGROUND

Medications used for pharmacologic venous thromboembolism prophylaxis are associated with postoperative complications including bleeding, wound complications, and infection. These same medications are used for chronic anticoagulation, and little research has been done on total knee arthroplasty (TKA) complications associated with these medications, particularly manipulation under anesthesia (MUA) and revision TKA. The purpose of this study is to evaluate the rate of MUA and other early postoperative complications in patients undergoing TKA with a preoperative history of chronic anticoagulation.

METHODS

The TriNetX database was retrospectively queried for all patients undergoing TKA with perioperative tranexamic acid. Patients were divided into cohorts by whether or not they had a history of chronic anticoagulant use and had an anticoagulant medication prescribed within 6 months of surgery. The cohorts were propensity score matched on demographic and comorbidity data; 7367 patients remained in each cohort after matching.

RESULTS

Patients with chronic anticoagulant use were 1.72 times more likely to undergo an MUA (odds ratio [OR]: 1.718, 95% confidence intervals [CI]: 1.403-2.104; < .001), 1.32 times more likely to have a revision TKA (OR: 1.324, 95% CI: 1.006-1.742;  = .044), and were 1.53 times more likely to have wound disruption (OR: 1.530, 95% CI: 1.214-1.927; < .001) within the 1-year postoperative period.

CONCLUSIONS

Patients undergoing TKA while on chronic anticoagulation have worse outcomes within 1 year postoperatively than patients not on chronic anticoagulation. Further studies are needed to validate these findings and to identify sources of the increased risk of complications in this population, as well as identify factors that may mitigate this risk.

摘要

背景

用于药物性静脉血栓栓塞预防的药物与术后并发症相关,包括出血、伤口并发症和感染。这些药物也用于慢性抗凝治疗,而关于这些药物与全膝关节置换术(TKA)并发症,特别是麻醉下手法操作(MUA)和TKA翻修术相关的研究较少。本研究的目的是评估有慢性抗凝治疗病史的患者在接受TKA时MUA的发生率及其他早期术后并发症。

方法

对TriNetX数据库进行回顾性查询,以获取所有接受TKA并围手术期使用氨甲环酸的患者。根据患者是否有慢性抗凝药物使用史以及在手术6个月内是否开具了抗凝药物处方,将患者分为不同队列。对各队列的人口统计学和合并症数据进行倾向评分匹配;匹配后每个队列各有7367例患者。

结果

有慢性抗凝药物使用史的患者接受MUA的可能性高1.72倍(比值比[OR]:1.718,95%置信区间[CI]:1.403 - 2.104;P <.001),进行TKA翻修术的可能性高1.32倍(OR:1.324,95%CI:1.006 - 1.742;P =.044),并且在术后1年内伤口裂开的可能性高1.53倍(OR:1.530,95%CI:1.214 - 1.927;P <.001)。

结论

接受TKA时正在进行慢性抗凝治疗的患者术后1年内的结局比未进行慢性抗凝治疗的患者更差。需要进一步研究来验证这些发现,并确定该人群并发症风险增加的来源,以及识别可能减轻这种风险的因素。

相似文献

1
The Effect of Chronic Anticoagulation on Early Postoperative Outcomes Following Total Knee Arthroplasty: A TriNetX Database Study.
Arthroplast Today. 2025 Apr 26;33:101690. doi: 10.1016/j.artd.2025.101690. eCollection 2025 Jun.
2
The association between losartan potassium prescription and postoperative outcomes following total knee arthroplasty: A TriNetX analysis.
Orthop Traumatol Surg Res. 2024 Nov;110(7):103851. doi: 10.1016/j.otsr.2024.103851. Epub 2024 Feb 28.
5
Arthrofibrosis after total knee arthroplasty: patients with keloids at risk.
J Orthop Traumatol. 2021 Jan 5;22(1):1. doi: 10.1186/s10195-020-00563-7.
7
Factors predicting manipulation under anaesthesia after total knee replacement.
Arch Orthop Trauma Surg. 2025 Jan 23;145(1):138. doi: 10.1007/s00402-025-05758-3.

本文引用的文献

1
Low-Dose Aspirin Is the Safest Prophylaxis for Prevention of Venous Thromboembolism After Total Knee Arthroplasty Across All Patient Risk Profiles.
J Bone Joint Surg Am. 2024 Jul 17;106(14):1256-1267. doi: 10.2106/JBJS.23.01158. Epub 2024 May 16.
3
The Efficacy and Safety of Tranexamic Acid in Total Hip and Knee Arthroplasty: A Literature Review.
HSS J. 2024 Feb;20(1):10-17. doi: 10.1177/15563316231208716. Epub 2023 Nov 2.
4
Tranexamic Acid Is Safe in Patients with a History of Venous Thromboembolism Undergoing Total Joint Arthroplasty.
J Bone Joint Surg Am. 2024 Jan 3;106(1):30-38. doi: 10.2106/JBJS.23.00254. Epub 2023 Nov 15.
5
Projections and Epidemiology of Primary Hip and Knee Arthroplasty in Medicare Patients to 2040-2060.
JB JS Open Access. 2023 Feb 28;8(1). doi: 10.2106/JBJS.OA.22.00112. eCollection 2023 Jan-Mar.
6
Safety and Efficacy of Rivaroxaban in Primary Total Hip and Knee Arthroplasty.
J Arthroplasty. 2023 Aug;38(8):1613-1620.e4. doi: 10.1016/j.arth.2023.02.028. Epub 2023 Feb 18.
7
Is Enoxaparin Associated With a Higher Risk of Persistent Wound Drainage Than Aspirin? A Secondary Analysis of Data From the CRISTAL Randomized Trial.
Clin Orthop Relat Res. 2023 Jul 1;481(7):1351-1359. doi: 10.1097/CORR.0000000000002544. Epub 2023 Jan 17.
8
Aspirin Administered for Venous Thromboembolism Prophylaxis May Protect Against Stiffness Following Total Knee Arthroplasty.
J Arthroplasty. 2022 May;37(5):953-957. doi: 10.1016/j.arth.2022.01.008. Epub 2022 Jan 10.
10
Perioperative Management of Chronic Antithrombotic Agents in Elective Hip and Knee Arthroplasty.
Medicina (Kaunas). 2021 Feb 23;57(2):188. doi: 10.3390/medicina57020188.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验